People who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa

Journal of the Association of Nurses in AIDS Care

Volumn 24, Issue 6, 2013, Pages

  Asher, Alice K ^a,b   Hahn, Judith A ^a   Couture, Marie Claude ^a   Maher, Kelsey ^a   Page, Kimberly ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV risk; HIV testing; Injection drug use; Stigma; Sub Saharan Africa

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; ATTITUDE TO HEALTH; DISEASE TRANSMISSION; DRUG USE; HEALTH CARE DELIVERY; HIGH RISK BEHAVIOR; HIV RISK; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION DRUG USE; MALE; PATIENT ATTITUDE; PREVALENCE; PSYCHOLOGICAL ASPECT; SERODIAGNOSIS; SEXUAL BEHAVIOR; STATISTICS; STIGMA; SUB-SAHARAN AFRICA; SUBSTANCE ABUSE; UTILIZATION REVIEW;

HIV RISK; HIV TESTING; INJECTION DRUG USE; STIGMA; SUB-SAHARAN AFRICA;

ADULT; AFRICA SOUTH OF THE SAHARA; AIDS SERODIAGNOSIS; DRUG USERS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84885432222     PISSN: 10553290     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jana.2012.09.003     Document Type: Article

References (45)

1. Abdool R., Sulluman F., Dhannoo M. The injecting drug use and HIV/AIDS nexus in the republic of Mauritius. African Journal of Drug & Alcohol Studies 2006, 5(2):108-116.
2. Aceijas C., Friedman S., Cooper H., Stimson G., Hickman M. Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sexually Transmitted Infections 2006, 82(4):iii10-iii17. 10.1136/sti.2005.019471.
3. Adeji A., Armah H., Gbagbo F., Ampofo W., Boamah I., Adu-Gyamfi C., Mensah G., et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study. BMC Infectious Diseases 2008, 8:33. 10.1186/1471-2334-8-33.
4. Adelekan M., Lawal R. Drug use and HIV infection in Nigeria: A review of recent findings. African Journal of Drug & Alcohol Studies 2006, 5(2):118-129.
5. Adoga M., Banwat E., Forbi J., Nimzing L., Pam C., Gyar S.D., Agwale S.M., et al. Human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. Journal of Infections in Developing Countries 2009, 3(7):539-547.
6. Affinnih Y. Revisiting sub-Saharan African countries' drugproblems: Health, social, economic costs, and drug control policy. Substance Use & Misuse 2002, 37(3):265-290. 10.1081/JA-120002479.
7. Alexander J. Death and disease in Zimbabwe's prisons. Lancet 2009, 373(9668):995-996. 10.1016/S0140-6736(09)60592-4.
8. Beckerleg S., Telfer M., Sadiq A. A rapid assessment of heroin use in Mombasa, Kenya. Substance Use & Misuse 2006, 41(6&7):1029-1044. 10.1080/10826080600667193.
9. Bisika T., Konyani S., Chamangwana I., Khanyizira G. An epidemiologic study of drug abuse and HIV and AIDS in Malawi. African Journal of Drug & Alcohol Studies 2008, 7(2):81-88.
10. Dahoma M., Salim A., Abdool R., Juma S., Yahya B., Shaka S., Kibuka T., et al. HIV and substance abuse: The dual epidemics challenging Zanzibar. African Journal of Drug & Alcohol Studies 2006, 5(2):130-139.
11. Dolan K., Kite B., Black E., Aceijas C., Stimson G. HIV in prison in low-income and middle-income countries. Lancet 2007, 7(1):32-41. doi:1016/S1473-3099(06)70685-5.
12. Essuon A., Simmons D., Stephens T., Richter D., Lindley L., Braithwaite R. Transient populations: Linking HIV, migrant workers, and South African male inmates. Journal of Health Care of the Poor & Underserved 2009, 20(2 Suppl):40-52.
13. France de Bravo B., Curtis M., Eagan E., Korpivaara A., Kramer W., Pinkham S., Wolfe D., et al. Harm reduction developments 2008: Countries with injection-driven HIV epidemics Retrieved from. http://www.soros.org/sites/default/files/developments_20080304.pdf.
14. Gisselquist D. Estimating HIV-1 transmission efficiency through unsafe medical injections. International Journal of STDs and AIDS 2002, 13:152-159. 10.1258/0956462021924820.
15. Hedden S., Whitaker D., Floyd L., Latimer W. Gender differences in the prevalence and behavioral risk factors of HIV in South African drug users. AIDS Behavior 2009, 13:288-296. 10.1007/s10461-008-9467-0.
16. Hendriksen E., Hlubinka D., Chariyalertsak S., Chingono A., Gray G., Mbwambo J., Coates T., et al. Keep talking about it: HIV/AIDS-related communication and prior HIV testing in Tanzania, Zimbabwe, South Africa and Thailand. AIDS Behavior 2009, 13(6):1213-1221. 10.1007/s10461-009-9608-0.
17. Joint United Nations Programme on HIV/AIDS. (2007). Injecting drug use: Focused HIV prevention works. Retrieved from http://www.unaids.org/en/Resources/PressCentre/Featurestories/2007/May/20070511BPHighcoveragesites/.
18. Joint United Nations Programme on HIV/AIDS. (2008). Epidemiological fact sheet on HIV and AIDS core data on epidemiology and response: Ghana. Retrieved from http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_GH.pdf.
19. Mathers B., Degenhardt L., Ali H., Wiessing L., Hickman M., Mattick R., Strathdee S., et al. HIV prevention, treatment and care services for people who inject drugs: A systematic review of global, regional and national coverage. Lancet 2010, 375:1014-1028. doi:1016/S0140-6736(10)60232-2.
20. Mathers B., Degenhardt L., Philips B., Wiessing L., Hickman M., Strathdee S., Mattick R., et al. Global epidemiology of injecting drug use and HIV among people who injectdrugs: A systematic review. Lancet 2008, 371:1733-1745. 10.1016/S0140-6736(08)61311-2.
21. Matovu J., Makumbi F. Expanding access to voluntary HIV counselling and testing in sub-Saharan Africa: Alternative aproaches for improving uptake, 2001-2007. Tropical Medicine and International Health 2007, 12(11):1315-1322. 10.1111/j.1365-3156.2007.01923.x.
22. McCurdy S., Ross M., Kilonzo G., Leshabari M., Williams M. HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania. Drug and Alcohol Dependence 2006, 82(Suppl 1):S23-S27. doi:0.1016/S0376-8716(06)80004-9.
23. McCurdy S., Williams M., Kilonzo G., Ross M., Leshabari M. Heroin and HIV risk in Dar es Salaam, Tanzania: Youth hangouts, mageto and injecting practices. AIDS Care 2005, 17(Suppl 1):S65-S76. 10.1080/09540120500120930.
24. McCurdy S., Williams M., Ross M., Kilonzo G., Leshabari M. A theme issue by, for and about Africa: New injecting practices increases HIV risk among drug users in Tanzania. British Medical Journal 2005, 331(7519):778. 10.1136/bmj.331.7519.
25. Meiberg A., Bos A., Onya H., Schaalma H. Fear of stigmatization as a barrier to voluntary HIV counselling and testing in South Africa. East African Journal of Public Health 2008, 5(2):49-54.
26. Montaner J., Lima V., Barrios R., Yip B., Wood E., Kerr T., Kendall P., et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. Lancet 2010, 376:532-539. 10.1016/S0140-6736(10)60936-1.
27. Moszynski P. Zambian prisons "threaten public health" because of high rates of TB and HIV. British Medical Journal 2010, 340:c2225. 10.1136/bmj.c2225.
28. Needle R., Kroeger K., Belani H., Hegle J. Substance abuse and HIV in sub-Saharan Africa: Introduction to the special issue. African Journal of Drug & Alcohol Studies 2006, 5(2):83-94.
29. Paintsil E., He H., Peters C., Lindenbach B., Heimer R. Survival of hepatitis C virus in syringes: Implications for transmisison among injection drug users. Journal of Infectious Diseases 2010, 202:984-990. 10.1097/01.ede.0000135170.54913.9d.
30. Palmateer N., Kimber J., Hickman M., Hutchinson S., Rhodes T., Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews. Addiction 2010, 105(5):860-861. 10.1111/j.1360-0443.2009.02888.x.
31. Parry C., Carney T., Petersen P., Dewing S., Needle R. HIV-risk behavior among injecting or non-injecting drug users in Cape Town, Pretoria, and Durban, South Africa. Substance Use & Misuse 2009, 44(6):886-904. 10.1080/10826080802487028.
32. Parry C., Petersen P., Carney T., Needle R. Opportunities for enhancing and integrating HIV and drug services for drug using vulnerable populations in South Africa. International Journal of Drug Policy 2010, 21:289-295. doi:1016/j.drugpo.2009.11.008.
33. Parry C., Pithey A. Risk behaviour and HIV among drug using populations in South Africa. African Journal of Drug & Alcohol Studies 2006, 5(2):140-157.
34. Pluddeman A., Parry C., Flisher A., Jordaan E. Heroin users in Cape Town, South Africa: Injecting practices, HIV-related risk behaviors, and other health consequences. Journal of Psychoactive Drugs 2008, 40(3):273-279. doi:1016/j.drugpo.2009.11.008.
35. Reid S. Injection drug use, unsafe medical injections and HIV in Africa: A systematic review. Harm Reduction 2009, 6(24). 10.1186/1477-7517-6-24.
36. Ross M., McCurdy S., Kilonzo G., Williams M., Leshabari M. Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. American Journal of Tropical Medicine 2008, 79(3):338-343.
37. Stimson G., Fitch C., DesJarlais D., Poznyak V., Perlis T., Oppenheimer E., Rhodes T. Rapid assessment and response studies of injection drug use: Knowledge gain, capacity building, and intervention development in a multisite study. American Journal of Public Health 2006, 96(2):288-295. 10.2105/AJPH.2003.035899.
38. Sullivan L., Levine B., Charwarski M., Schottenfeld R., Fiellin D. Addiction and HIV in Kenya: A description of treatment serivces and integration. African Journal of Drug & Alcohol Studies 2007, 6(1):17-26.
39. Timpson S., McCurdy S., Leshabari M., Kilonzo G., Atkinson J., Msami A., Williams M. Substance abuse, HIV risk and HIV/AIDS in Tanzania. African Journal of Drug & Alcohol Studies 2006, 5(2):158-169.
40. United Nations Office for Drug Control and Crime Provention. (2011). World drug report 2011. Retrieved from http://www.unodc.org/unodc/en/frontpage/2011/June/wdr-2011%13-drug-markets-stable-but-consumption-of-synthetic-and-prescription-drugs-rises.html.
41. Wechsberg W., Wu L., Zule W., Parry C., Browne F., Luseno W., Gentry A., et al. Substance abuse, treatment needs and access among female sex workers and non-sex workers in Pretoria, South Africa. Substance Abuse Treatment, Prevention and Policy 2009, 4(11). 10.1186/1747-597X-4-11.
42. Williams M., McCurdy S., Atkinson J., Kilonzo G., Leshabari M., Ross M. Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users. AIDS Behavior 2007, 11:137-144. 10.1007/s10461-006-9102-x.
43. Williams M., McCurdy S., Bowen A., Kilonzo G., Atkinson J., Ross M., Leshabari M. HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Education and Prevention 2009, 21(5):474-483. 10.1521/aeap.2009.21.5.474.
44. World Health Organization. (2006). Treatment of injecting drug users with HIV/AIDS: Promoting access and optimizing services delivery. Retrieved from http://www.who.int/substance_abuse/publications/treatment_idus_hiv_aids.pdf.
45. World Health Organization, United Nations Office on Drugs and Crime, & Joint United Nations Programme on HIV/AIDS. (2008). Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Retrieved from http://www.unodc.org/documents/hiv-aids/WHO%20UNODC%20UNAIDS%20%20IDU%20Universal%20Access%20Target%20Setting%20Guide%20-%20FINAL%20-%20Feb%2009.pdf.